Strategies to halt 2019 novel coronavirus (SARS‐CoV‐2) spread for organ transplantation programs at the Sichuan Academy of Medical Science and Sichuan Provincial People’s Hospital, China
During the 2019 novel coronavirus (SARS‐CoV‐2) outbreak in China (from January 24 to March 11, 2020), our center performed 16 organ transplants (10 kidney, 4 liver, and 2 lung transplants) harvested from deceased donors. Regarding the strategies to prevent infections of SARS‐CoV‐2, we implemented sp...
Gespeichert in:
| Veröffentlicht in: | American journal of transplantation 2020-07, Vol.20 (7), p.1837-1839 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1839 |
|---|---|
| container_issue | 7 |
| container_start_page | 1837 |
| container_title | American journal of transplantation |
| container_volume | 20 |
| creator | Wang, Yi Yang, Hongji Liu, Huirong Buhler, Leo H. Deng, Shaoping |
| description | During the 2019 novel coronavirus (SARS‐CoV‐2) outbreak in China (from January 24 to March 11, 2020), our center performed 16 organ transplants (10 kidney, 4 liver, and 2 lung transplants) harvested from deceased donors. Regarding the strategies to prevent infections of SARS‐CoV‐2, we implemented specific measures for the donor and recipient management, as well as prevention of hospital‐acquired infections. All 16 organ recipients had a favorable outcome without SARS‐CoV‐2 infection. Our approaches aiming to interrupt the spread of SARS‐CoV‐2 within the transplantation wards were successful, and allowed us to maintain the transplantation program for deceased liver, kidney, and lung organ recipients.
The authors report here their approaches to interrupt the spread of SARS‐CoV‐2 within the transplantation wards of their institution, which allowed maintenance of the transplantation programs for deceased liver, kidney, and lung recipients. |
| doi_str_mv | 10.1111/ajt.15972 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7267276</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2397685449</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4712-e37400f24bee36d59e63d28eefaeb155e2824546ebd868def570208d7aeaaf5a3</originalsourceid><addsrcrecordid>eNp1ktFqFDEUhgdRbK1e-AIS8KYFt00yk8nMTWFZ1CoVi1O9DWczZ3azzCZjklnZuz6Ct76Nz9InMbp1UcFcJIHz8XHO4c-yp4yesnTOYBVPmaglv5cdspLSScmK_P7-n4uD7FEIK0qZ5BV_mB3kPBc1q6rD7HsTPURcGAwkOrKEPhJOWU2s22BPtPPOwsb4MZDjZvqhub35OnOf0s1PSBg8Qks654nzC7AkqWwYerARonGWDN4tPKwDgUjiEklj9HJM3FRDi-stcR15h63R0JNGG7QaCdh2j115tzFWm1S-Qjf0eHvzLZALFwYToX9BZktj4XH2oIM-4JO79yj7-Orl9exicvn-9ZvZ9HKiC8n4BHNZUNrxYo6Yl62oscxbXiF2gHMmBKbFFKIocd5WZdViJyTltGolIEAnID_KznfeYZyvsdVo07S9GrxZg98qB0b9XbFmqRZuoyQvJZdlEhzfCbz7PGKIam2Cxj6tC90YFM9rWVaiKOqEPv8HXbnR2zSe4gWTtchzLhJ1sqO0dyF47PbNMKp-5kKlXKhfuUjssz-735O_g5CAsx3wxfS4_b9JTd9e75Q_AB5dx-0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2417953325</pqid></control><display><type>article</type><title>Strategies to halt 2019 novel coronavirus (SARS‐CoV‐2) spread for organ transplantation programs at the Sichuan Academy of Medical Science and Sichuan Provincial People’s Hospital, China</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Wiley Online Library All Journals</source><source>Alma/SFX Local Collection</source><creator>Wang, Yi ; Yang, Hongji ; Liu, Huirong ; Buhler, Leo H. ; Deng, Shaoping</creator><creatorcontrib>Wang, Yi ; Yang, Hongji ; Liu, Huirong ; Buhler, Leo H. ; Deng, Shaoping</creatorcontrib><description>During the 2019 novel coronavirus (SARS‐CoV‐2) outbreak in China (from January 24 to March 11, 2020), our center performed 16 organ transplants (10 kidney, 4 liver, and 2 lung transplants) harvested from deceased donors. Regarding the strategies to prevent infections of SARS‐CoV‐2, we implemented specific measures for the donor and recipient management, as well as prevention of hospital‐acquired infections. All 16 organ recipients had a favorable outcome without SARS‐CoV‐2 infection. Our approaches aiming to interrupt the spread of SARS‐CoV‐2 within the transplantation wards were successful, and allowed us to maintain the transplantation program for deceased liver, kidney, and lung organ recipients.
The authors report here their approaches to interrupt the spread of SARS‐CoV‐2 within the transplantation wards of their institution, which allowed maintenance of the transplantation programs for deceased liver, kidney, and lung recipients.</description><identifier>ISSN: 1600-6135</identifier><identifier>EISSN: 1600-6143</identifier><identifier>DOI: 10.1111/ajt.15972</identifier><identifier>PMID: 32359188</identifier><language>eng</language><publisher>United States: Elsevier Limited</publisher><subject>Betacoronavirus ; Brief Communication ; Brief Communications ; China - epidemiology ; Clinical Laboratory Techniques ; clinical research/practice ; Communicable Disease Control ; Coronaviridae ; Coronavirus Infections - diagnosis ; Coronavirus Infections - prevention & control ; Coronavirus Infections - transmission ; Coronaviruses ; COVID-19 ; COVID-19 Testing ; Cross Infection - prevention & control ; Humans ; infection and infectious agents ; infection and infectious agents—viral ; infectious disease ; Intensive Care Units ; Kidney Transplantation ; Kidneys ; Liver Transplantation ; Lung Transplantation ; Organ Transplantation - methods ; Organ Transplantation - trends ; organ transplantation in general ; Pandemics - prevention & control ; Pneumonia, Viral - prevention & control ; Pneumonia, Viral - transmission ; SARS-CoV-2 ; Severe acute respiratory syndrome coronavirus 2 ; Tissue Donors ; Transplants & implants ; Treatment Outcome</subject><ispartof>American journal of transplantation, 2020-07, Vol.20 (7), p.1837-1839</ispartof><rights>2020 The American Society of Transplantation and the American Society of Transplant Surgeons</rights><rights>2020 The American Society of Transplantation and the American Society of Transplant Surgeons.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4712-e37400f24bee36d59e63d28eefaeb155e2824546ebd868def570208d7aeaaf5a3</citedby><cites>FETCH-LOGICAL-c4712-e37400f24bee36d59e63d28eefaeb155e2824546ebd868def570208d7aeaaf5a3</cites><orcidid>0000-0003-2572-7487</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fajt.15972$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fajt.15972$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,780,784,885,1416,27923,27924,45573,45574</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32359188$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Yi</creatorcontrib><creatorcontrib>Yang, Hongji</creatorcontrib><creatorcontrib>Liu, Huirong</creatorcontrib><creatorcontrib>Buhler, Leo H.</creatorcontrib><creatorcontrib>Deng, Shaoping</creatorcontrib><title>Strategies to halt 2019 novel coronavirus (SARS‐CoV‐2) spread for organ transplantation programs at the Sichuan Academy of Medical Science and Sichuan Provincial People’s Hospital, China</title><title>American journal of transplantation</title><addtitle>Am J Transplant</addtitle><description>During the 2019 novel coronavirus (SARS‐CoV‐2) outbreak in China (from January 24 to March 11, 2020), our center performed 16 organ transplants (10 kidney, 4 liver, and 2 lung transplants) harvested from deceased donors. Regarding the strategies to prevent infections of SARS‐CoV‐2, we implemented specific measures for the donor and recipient management, as well as prevention of hospital‐acquired infections. All 16 organ recipients had a favorable outcome without SARS‐CoV‐2 infection. Our approaches aiming to interrupt the spread of SARS‐CoV‐2 within the transplantation wards were successful, and allowed us to maintain the transplantation program for deceased liver, kidney, and lung organ recipients.
The authors report here their approaches to interrupt the spread of SARS‐CoV‐2 within the transplantation wards of their institution, which allowed maintenance of the transplantation programs for deceased liver, kidney, and lung recipients.</description><subject>Betacoronavirus</subject><subject>Brief Communication</subject><subject>Brief Communications</subject><subject>China - epidemiology</subject><subject>Clinical Laboratory Techniques</subject><subject>clinical research/practice</subject><subject>Communicable Disease Control</subject><subject>Coronaviridae</subject><subject>Coronavirus Infections - diagnosis</subject><subject>Coronavirus Infections - prevention & control</subject><subject>Coronavirus Infections - transmission</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>COVID-19 Testing</subject><subject>Cross Infection - prevention & control</subject><subject>Humans</subject><subject>infection and infectious agents</subject><subject>infection and infectious agents—viral</subject><subject>infectious disease</subject><subject>Intensive Care Units</subject><subject>Kidney Transplantation</subject><subject>Kidneys</subject><subject>Liver Transplantation</subject><subject>Lung Transplantation</subject><subject>Organ Transplantation - methods</subject><subject>Organ Transplantation - trends</subject><subject>organ transplantation in general</subject><subject>Pandemics - prevention & control</subject><subject>Pneumonia, Viral - prevention & control</subject><subject>Pneumonia, Viral - transmission</subject><subject>SARS-CoV-2</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Tissue Donors</subject><subject>Transplants & implants</subject><subject>Treatment Outcome</subject><issn>1600-6135</issn><issn>1600-6143</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1ktFqFDEUhgdRbK1e-AIS8KYFt00yk8nMTWFZ1CoVi1O9DWczZ3azzCZjklnZuz6Ct76Nz9InMbp1UcFcJIHz8XHO4c-yp4yesnTOYBVPmaglv5cdspLSScmK_P7-n4uD7FEIK0qZ5BV_mB3kPBc1q6rD7HsTPURcGAwkOrKEPhJOWU2s22BPtPPOwsb4MZDjZvqhub35OnOf0s1PSBg8Qks654nzC7AkqWwYerARonGWDN4tPKwDgUjiEklj9HJM3FRDi-stcR15h63R0JNGG7QaCdh2j115tzFWm1S-Qjf0eHvzLZALFwYToX9BZktj4XH2oIM-4JO79yj7-Orl9exicvn-9ZvZ9HKiC8n4BHNZUNrxYo6Yl62oscxbXiF2gHMmBKbFFKIocd5WZdViJyTltGolIEAnID_KznfeYZyvsdVo07S9GrxZg98qB0b9XbFmqRZuoyQvJZdlEhzfCbz7PGKIam2Cxj6tC90YFM9rWVaiKOqEPv8HXbnR2zSe4gWTtchzLhJ1sqO0dyF47PbNMKp-5kKlXKhfuUjssz-735O_g5CAsx3wxfS4_b9JTd9e75Q_AB5dx-0</recordid><startdate>202007</startdate><enddate>202007</enddate><creator>Wang, Yi</creator><creator>Yang, Hongji</creator><creator>Liu, Huirong</creator><creator>Buhler, Leo H.</creator><creator>Deng, Shaoping</creator><general>Elsevier Limited</general><general>John Wiley and Sons Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7T5</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-2572-7487</orcidid></search><sort><creationdate>202007</creationdate><title>Strategies to halt 2019 novel coronavirus (SARS‐CoV‐2) spread for organ transplantation programs at the Sichuan Academy of Medical Science and Sichuan Provincial People’s Hospital, China</title><author>Wang, Yi ; Yang, Hongji ; Liu, Huirong ; Buhler, Leo H. ; Deng, Shaoping</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4712-e37400f24bee36d59e63d28eefaeb155e2824546ebd868def570208d7aeaaf5a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Betacoronavirus</topic><topic>Brief Communication</topic><topic>Brief Communications</topic><topic>China - epidemiology</topic><topic>Clinical Laboratory Techniques</topic><topic>clinical research/practice</topic><topic>Communicable Disease Control</topic><topic>Coronaviridae</topic><topic>Coronavirus Infections - diagnosis</topic><topic>Coronavirus Infections - prevention & control</topic><topic>Coronavirus Infections - transmission</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>COVID-19 Testing</topic><topic>Cross Infection - prevention & control</topic><topic>Humans</topic><topic>infection and infectious agents</topic><topic>infection and infectious agents—viral</topic><topic>infectious disease</topic><topic>Intensive Care Units</topic><topic>Kidney Transplantation</topic><topic>Kidneys</topic><topic>Liver Transplantation</topic><topic>Lung Transplantation</topic><topic>Organ Transplantation - methods</topic><topic>Organ Transplantation - trends</topic><topic>organ transplantation in general</topic><topic>Pandemics - prevention & control</topic><topic>Pneumonia, Viral - prevention & control</topic><topic>Pneumonia, Viral - transmission</topic><topic>SARS-CoV-2</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Tissue Donors</topic><topic>Transplants & implants</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Yi</creatorcontrib><creatorcontrib>Yang, Hongji</creatorcontrib><creatorcontrib>Liu, Huirong</creatorcontrib><creatorcontrib>Buhler, Leo H.</creatorcontrib><creatorcontrib>Deng, Shaoping</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>American journal of transplantation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Yi</au><au>Yang, Hongji</au><au>Liu, Huirong</au><au>Buhler, Leo H.</au><au>Deng, Shaoping</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Strategies to halt 2019 novel coronavirus (SARS‐CoV‐2) spread for organ transplantation programs at the Sichuan Academy of Medical Science and Sichuan Provincial People’s Hospital, China</atitle><jtitle>American journal of transplantation</jtitle><addtitle>Am J Transplant</addtitle><date>2020-07</date><risdate>2020</risdate><volume>20</volume><issue>7</issue><spage>1837</spage><epage>1839</epage><pages>1837-1839</pages><issn>1600-6135</issn><eissn>1600-6143</eissn><abstract>During the 2019 novel coronavirus (SARS‐CoV‐2) outbreak in China (from January 24 to March 11, 2020), our center performed 16 organ transplants (10 kidney, 4 liver, and 2 lung transplants) harvested from deceased donors. Regarding the strategies to prevent infections of SARS‐CoV‐2, we implemented specific measures for the donor and recipient management, as well as prevention of hospital‐acquired infections. All 16 organ recipients had a favorable outcome without SARS‐CoV‐2 infection. Our approaches aiming to interrupt the spread of SARS‐CoV‐2 within the transplantation wards were successful, and allowed us to maintain the transplantation program for deceased liver, kidney, and lung organ recipients.
The authors report here their approaches to interrupt the spread of SARS‐CoV‐2 within the transplantation wards of their institution, which allowed maintenance of the transplantation programs for deceased liver, kidney, and lung recipients.</abstract><cop>United States</cop><pub>Elsevier Limited</pub><pmid>32359188</pmid><doi>10.1111/ajt.15972</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0003-2572-7487</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1600-6135 |
| ispartof | American journal of transplantation, 2020-07, Vol.20 (7), p.1837-1839 |
| issn | 1600-6135 1600-6143 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7267276 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Wiley Online Library All Journals; Alma/SFX Local Collection |
| subjects | Betacoronavirus Brief Communication Brief Communications China - epidemiology Clinical Laboratory Techniques clinical research/practice Communicable Disease Control Coronaviridae Coronavirus Infections - diagnosis Coronavirus Infections - prevention & control Coronavirus Infections - transmission Coronaviruses COVID-19 COVID-19 Testing Cross Infection - prevention & control Humans infection and infectious agents infection and infectious agents—viral infectious disease Intensive Care Units Kidney Transplantation Kidneys Liver Transplantation Lung Transplantation Organ Transplantation - methods Organ Transplantation - trends organ transplantation in general Pandemics - prevention & control Pneumonia, Viral - prevention & control Pneumonia, Viral - transmission SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Tissue Donors Transplants & implants Treatment Outcome |
| title | Strategies to halt 2019 novel coronavirus (SARS‐CoV‐2) spread for organ transplantation programs at the Sichuan Academy of Medical Science and Sichuan Provincial People’s Hospital, China |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T10%3A50%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Strategies%20to%20halt%202019%20novel%20coronavirus%20(SARS%E2%80%90CoV%E2%80%902)%20spread%20for%20organ%20transplantation%20programs%20at%20the%20Sichuan%20Academy%20of%20Medical%20Science%20and%20Sichuan%20Provincial%20People%E2%80%99s%20Hospital,%20China&rft.jtitle=American%20journal%20of%20transplantation&rft.au=Wang,%20Yi&rft.date=2020-07&rft.volume=20&rft.issue=7&rft.spage=1837&rft.epage=1839&rft.pages=1837-1839&rft.issn=1600-6135&rft.eissn=1600-6143&rft_id=info:doi/10.1111/ajt.15972&rft_dat=%3Cproquest_pubme%3E2397685449%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2417953325&rft_id=info:pmid/32359188&rfr_iscdi=true |